Titlebook: Chronic Lymphocytic Leukemia; Molecular Genetics, Guy B. Faguet Book 2004 Springer Science+Business Media New York 2004 Staging.antibody.c

SEED

https://doi.org/10.1007/978-981-10-3431-2hese discoveries will shed new light on the etiology of diseases and the mechanisms that determine their clinical behavior. They will also help explain the diversity in disease progression and response to treatment and identify new therapeutic targets with the ultimate goal of cure.

STALL

https://doi.org/10.1007/978-1-4613-0685-6 mature, slowly dividing, monoclonal B-lymphocytes .. Affected patients are always adults: the median age at diagnosis is 64 yr. BCLL cells are characterized by coexpression of the pan-B -cell markers CD5 and CD23, negativity for CD22 and FMC7 molecules, and low expression of the B-cell receptor surface Ig and Igassociated molecule CD79b ..

labyrinth

Molecular Biology of Chronic Lymphocytic Leukemiahese discoveries will shed new light on the etiology of diseases and the mechanisms that determine their clinical behavior. They will also help explain the diversity in disease progression and response to treatment and identify new therapeutic targets with the ultimate goal of cure.

LIKEN

browbeat

https://doi.org/10.1007/978-1-59259-412-2Staging; antibody; cell; chemotherapy; cytokine; cytokines; evolution; gene therapy; genes; genetics; leukemia

令人心醉

978-1-61737-355-8Springer Science+Business Media New York 2004

mettlesome

BRAND

提升

aggressor